Abstract
e12652Background: A combination of Pertuzumab (P),trastuzumab (H) and chemotherapy is the standard of care for the neo-adjuvant treatment of locally advanced/inflammatory Her-2 +ve breast cancer. N...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
